Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Rab geranylgeranyltransferase subunit beta (RABGGTB) forms part of the catalytic core of RabGGTase, a heterodimeric enzyme comprised of alpha and beta subunits. This enzyme is responsible for transferring geranylgeranyl groups to Rab GTPases, which is critical for their association with cellular membranes and, consequently, for regulating vesicular transport processes. The beta subunit contains most of the active site residues, forming an alpha-alpha barrel with a deep prenyl-binding pocket and coordinating catalytic metal ions (Zn²⁺ and Ca²⁺). RabGGTase does not recognize Rab substrates alone but requires Rab escort protein (REP) to present Rab GTPases for prenylation. Unlike type I enzyme, it works broadly on Rab proteins, outsourcing substrate recognition to REP, thereby enabling modification of many different Rab GTPases involved in trafficking, secretion, and possibly disease pathogenesis. Bisphosphonate drugs, used in the treatment of bone diseases, can inhibit RabGGTase, although their effectiveness varies in vivo. If you need details for the alpha subunit or the whole enzyme, those differ but are closely related. The beta subunit specifically refers to the structural and catalytic protein encoded by the *RABGGTB* gene.
Inhibition of RabGGTase prevents geranylgeranylation of Rab proteins, affecting their localization and function (resulting in disruption of vesicular trafficking and osteoclast activity)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Rab geranylgeranyltransferase subunit beta.